Penn Medicine Provider
Dermatology
Jina Chung, MD
4.8
(372)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737

About me

  • Assistant Professor of Clinical Dermatology

Education and training

  • Medical School: Johns Hopkins University School of Medicine
  • Residency: Mount Sinai Beth Israel
  • Residency: University of Iowa Hospitals and Clinics
  • Fellowship: Thomas Jefferson University Hospital

What my patients think about me

Average Rating
4.8

372 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
timely and thorough
May 2025
5.0
5.0
extremely caring
May 2025
5.0
5.0
she is very knowledgeable
April 2025
5.0
5.0
very kind and professional.

Insurance accepted

My Locations

Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Chung is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Elghawy O, Yang AG, Sussman JH, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Villasenor-Park J, Plastaras JP, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK. Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome , J Am Acad Dermatol, 92(3): 2025,634-636

Mou E, Chung J. Cutaneous T-cell Lymphomas Update: Benefits of a Multidisciplinary Care Approach. , Rare Diseases Report: Cancers. MDedge/Hematology-Oncology: 2024

Alvarado SM, Cohen OG, Lattanzio K, Haun P, Gelfand JM, Loren AW, Chung J, Baumrin E. Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease , Am J Dermatopathol, 46(11): 2024,755-760

Miles JA, Kim E, Barta SK, Micheletti R, Chung J, Seykora J Folliculotropic mycosis fungoides with CD30 positive large cell transformation preceded by dissecting cellulitis of the scalp. , American Society of Dermatopathology meeting, Chicago, IL: 2024

Villasenor-Park J, Chung J, Kim EJ. Cutaneous B-Cell Lymphomas , Hematol Oncol Clin North Am, 38(5): 2024,1111-1131

Phillips GS, Knapp M, Olsen KC, Martin W, Hayes-Lattin B, Chung J. Multisystem ALK-Positive Histiocytosis With DCTN1::ALK Fusion in an Adult, Responsive to Alectinib: Case Report and Literature Review , J Cutan Pathol: 2024

Silva GS, Kim EJ, Barta SK, Chung J. Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature , Expert Rev Anticancer Ther, 24(9): 2024,819-827

Cutaneous Lymphoma Foundation: 2024 International Patient Conference Cutaneous Lymphoma: For the Newly Diagnosed , YouTube: https://www.youtube.com/watch?v=u0aj-vADW30: 2024

Elghawy O, Thomas CJ, Carter JS, Landsburg DJ, Svoboda J, Kim E, Rook AH, Chung J, Plastaras J, LaRiviere M, Hubbeling H, Chelius M, Nasta SD, Chong EA, Schuster SJ, Barta SK Single institution experience of pembrolizumab for patients with relapsed/refractory mycosis fungoides or Sezary syndrome , Society of Hematologic Oncology meeting, Houston, TX: 2024

Bash GN, Chung J, Fett N. An Isolated Cutaneous Nodule: Dupilumab-Induced Sarcoid-Like Reaction , Cureus, 16: 2024,e68061